By inactivating interleukin 6 (IL6), HOCl possibly downregulates mediators of the ‘cytokine storm’ that characterizes clinical deterioration in specific diseases (e.g., COVID-19) [48], [52], [53]. This evidence concerns the gene IL6 and COVID-19.